Brii Biosciences Limited (BRIBF)
USD 0.13
(0.0%)
USD 0.13
(0.0%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -168.2 Million CNY | 14.45% |
| 2022 | -471.89 Million CNY | 88.06% |
| 2021 | -4.21 Billion CNY | -236.69% |
| 2020 | -1.25 Billion CNY | -141.95% |
| 2019 | -517.72 Million CNY | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | -14.67 Million USD | 0.0% |
| 2024 Q1 | -14.76 Million USD | 22.5% |
| 2023 Q4 | -39.7 Million USD | -110.69% |
| 2023 FY | - CNY | 14.45% |
| 2023 Q3 | -18.84 Million USD | 56.05% |
| 2023 Q2 | -42.88 Million USD | -124.73% |
| 2023 Q1 | -19.08 Million USD | 35.65% |
| 2022 Q2 | -55.53 Million USD | 0.0% |
| 2022 FY | - CNY | 88.06% |
| 2022 Q4 | -29.65 Million USD | 0.0% |
| 2021 FY | - CNY | -236.69% |
| 2021 Q4 | -72.65 Million USD | 0.0% |
| 2021 Q2 | -33.62 Million USD | 0.0% |
| 2020 Q2 | -42.77 Million USD | 0.0% |
| 2020 FY | - CNY | -141.95% |
| 2020 Q4 | -98.06 Million USD | 0.0% |
| 2019 FY | - CNY | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Eiger BioPharmaceuticals, Inc. | -71.03 Million USD | -136.784% |
| Nanobac Pharmaceuticals, Incorporated | -5.92 Million USD | -2736.981% |
| SQZ Biotechnologies Company | -64.14 Million USD | -162.238% |
| Evofem Biosciences, Inc. | -17.37 Million USD | -868.348% |
| Santhera Pharmaceuticals Holding AG | 94.03 Million USD | 278.866% |
| Mesoblast Limited | -62.38 Million USD | -169.599% |
| Propanc Biopharma, Inc. | -1.53 Million USD | -10850.302% |
| Genus plc | 73.7 Million USD | 328.225% |
| VioQuest Pharmaceuticals, Inc. | -6.61 Million USD | -2444.076% |
| CNBX Pharmaceuticals Inc. | -3.54 Million USD | -4642.095% |
| Marizyme, Inc. | -34.28 Million USD | -390.65% |
| ContraFect Corporation | -64.99 Million USD | -158.776% |
| Nymox Pharmaceutical Corporation | -8.77 Million USD | -1817.487% |
| PsyBio Therapeutics Corp. | -4.52 Million USD | -3616.19% |
| Sienna Biopharmaceuticals, Inc. | - USD | Infinity% |
| RegeneRx Biopharmaceuticals, Inc. | -1.4 Million USD | -11898.933% |
| Intellipharmaceutics International Inc. | -2.64 Million USD | -6260.571% |
| AXIM Biotechnologies, Inc. | -2.32 Million USD | -7138.168% |
| MultiCell Technologies, Inc. | -518.04 Thousand USD | -32368.545% |
| Accustem Sciences Inc. | -3.74 Million USD | -4389.674% |
| RVL Pharmaceuticals plc | -48.22 Million USD | -248.771% |
| EV Biologics, Inc. | -1.26 Million USD | -13174.229% |
| Q BioMed Inc. | -617.62 Thousand USD | -27133.545% |
| Emmaus Life Sciences, Inc. | 3.57 Million USD | 4808.903% |
| Neon Bloom, Inc. | -632.4 Thousand USD | -26497.154% |
| Mosaic ImmunoEngineering Inc. | -2.28 Million USD | -7262.784% |
| Biomind Labs Inc. | -1.03 Million USD | -16158.486% |
| TetraLogic Pharmaceuticals Corporation | - USD | Infinity% |
| Pharming Group N.V. | 9.87 Million USD | 1802.966% |
| Oncotelic Therapeutics, Inc. | -7.16 Million USD | -2248.772% |
| Skye Bioscience, Inc. | -13.54 Million USD | -1141.568% |
| Therapeutic Solutions International, Inc. | -1.48 Million USD | -11208.366% |
| THC Farmaceuticals, Inc. | -25 Thousand USD | -672708.0% |
| Arch Therapeutics, Inc. | -3.88 Million USD | -4230.282% |
| IMV Inc. | -35.52 Million USD | -373.496% |
| Acro Biomedical Co., Ltd. | -15.86 Million USD | -959.892% |
| Curative Biotechnology, Inc. | -2.5 Million USD | -6622.804% |
| GB Sciences, Inc. | -1.41 Million USD | -11746.171% |
| Alpha Cognition Inc. | -9.7 Million USD | -1633.041% |
| HST Global, Inc. | -5303.00 USD | -3171727.268% |
| CSL Limited | 4.78 Billion USD | 103.512% |
| Halberd Corporation | -74.27 Thousand USD | -226346.236% |
| Enzolytics Inc. | -2.12 Million USD | -7826.47% |
| Resverlogix Corp. | -11.74 Million USD | -1332.482% |
| Affymax, Inc. | -14.29 Million USD | -1076.649% |
| SYBLEU INC | -141.57 Thousand USD | -118711.056% |
| Nuo Therapeutics, Inc. | -3.06 Million USD | -5391.385% |
| argenx SE | -216.02 Million USD | 22.137% |
| MetaStat, Inc. | - USD | Infinity% |
| Northwest Biotherapeutics, Inc. | -55.33 Million USD | -203.948% |
| Enzon Pharmaceuticals, Inc. | 1.21 Million USD | 13921.035% |
| Arno Therapeutics, Inc. | - USD | Infinity% |
| RespireRx Pharmaceuticals Inc. | -1.49 Million USD | -11121.651% |
| GeneThera, Inc. | - USD | Infinity% |
| Inhibitor Therapeutics, Inc. | 378.84 Thousand USD | 44498.75% |
| AVAX Technologies, Inc. | -6.11 Million USD | -2651.707% |
| Zenith Capital Corp. | -8.6 Million USD | -1854.474% |
| Genscript Biotech Corporation | -248.71 Million USD | 32.373% |
| Ember Therapeutics, Inc. | -17.42 Thousand USD | -965412.887% |
| Anthera Pharmaceuticals, Inc. | - USD | Infinity% |
| Sigyn Therapeutics, Inc. | -2.44 Million USD | -6775.319% |
| WPD Pharmaceuticals Inc. | -176.02 Thousand USD | -95456.092% |
| American Oriental Bioengineering, Inc. | -39.63 Million USD | -324.358% |
| Provectus Biopharmaceuticals, Inc. | -2.89 Million USD | -5715.458% |
| Adynxx, Inc. | - USD | Infinity% |
| Helix BioMedix, Inc. | -1.04 Million USD | -15975.702% |
| GlobeStar Therapeutics Corporation | 6724.00 USD | 2501616.954% |
| VitaSpring Biomedical Co. Ltd. | - USD | Infinity% |
| Capstone Therapeutics Corp. | -1.74 Million USD | -9511.548% |
| Cotinga Pharmaceuticals Inc. | -1.92 Million USD | -8656.366% |
| BioStem Technologies, Inc. | -7.55 Million USD | -2126.766% |
| ONE Bio Corp. | 13.61 Million USD | 1335.594% |
| Reve Technologies, Inc. | -181.08 Thousand USD | -92784.123% |
| Burzynski Research Institute, Inc. | - USD | Infinity% |
| Wesana Health Holdings Inc. | -2.05 Million USD | -8077.054% |
| Agentix Corp. | -1.37 Million USD | -12161.802% |
| LadRx Corporation | 412.28 Thousand USD | 40897.704% |
| Cell Source, Inc. | -4.27 Million USD | -3836.828% |
| ProtoKinetix, Incorporated | -367.22 Thousand USD | -45704.025% |
| Regen BioPharma, Inc. | 1.46 Million USD | 11573.878% |
| Regen BioPharma, Inc. | -936.94 Thousand USD | -17852.098% |
| NovAccess Global Inc. | -1.03 Million USD | -16154.589% |
| Endonovo Therapeutics, Inc. | 8.85 Million USD | 1999.772% |
| Itoco Inc. | -1.86 Million USD | -8899.596% |
| Rasna Therapeutics, Inc. | -379.62 Thousand USD | -44207.992% |
| Pathfinder Cell Therapy, Inc. | -1.11 Million USD | -14971.864% |
| Kadimastem Ltd | -2.62 Million USD | -6309.207% |
| Oncology Pharma Inc. | - USD | Infinity% |
| Institute of Biomedical Research Corp. | -239.15 Thousand USD | -70233.264% |
| CytoDyn Inc. | -18.02 Million USD | -832.952% |
| Claritas Pharmaceuticals, Inc. | - USD | Infinity% |
| NDT Pharmaceuticals Inc. | -79.02 Thousand USD | -212735.794% |
| Mobile Lads Corp. | -2.24 Million USD | -7405.135% |
| NanoSphere Health Sciences Inc. | -12.22 Thousand USD | -1375335.44% |
| Qrons Inc. | -40.08 Thousand USD | -419555.198% |
| Alseres Pharmaceuticals, Inc. | -485.67 Thousand USD | -34532.411% |
| Advanced Proteome Therapeutics Corporation | - USD | Infinity% |
| Nascent Biotech, Inc. | 527.43 Thousand USD | 31990.686% |
| Rebus Holdings, Inc. | -951 Thousand USD | -17586.856% |
| ImmunoCellular Therapeutics, Ltd. | -1.06 Million USD | -15738.081% |
| International Stem Cell Corporation | 202 Thousand USD | 83368.317% |
| Bioxytran, Inc. | -3.82 Million USD | -4303.024% |
| GlobeImmune, Inc. | - USD | Infinity% |
| Predictive Technology Group, Inc. | - USD | Infinity% |
| ProText Mobility, Inc. | -52.64 Thousand USD | -319432.675% |
| Cardax, Inc. | - USD | Infinity% |
| VG Life Sciences Inc. | -2.46 Million USD | -6732.114% |
| Kaleido Biosciences, Inc. | - USD | Infinity% |
| Advaxis, Inc. | -35.86 Million USD | -368.934% |
| Adhera Therapeutics, Inc. | - USD | Infinity% |
| RenovaCare, Inc. | - USD | Infinity% |
| Regnum Corp. | -45 Thousand USD | -373682.222% |
| Innovation Pharmaceuticals Inc. | -2.73 Million USD | -6043.243% |
| Neutra Corp. | -181.24 Thousand USD | -92702.639% |
| Windtree Therapeutics, Inc. | -20.15 Million USD | -734.377% |
| PureTech Health plc | -11.62 Million USD | -1346.65% |
| Coeptis Therapeutics, Inc. | -20.15 Million USD | -734.434% |
| IXICO plc | -707 Thousand USD | -23690.948% |
| IntelGenx Technologies Corp. | -7.68 Million USD | -2088.705% |
| Gelesis Holdings, Inc. | -48.34 Million USD | -247.913% |
| CSL Limited | 4.73 Billion USD | 103.554% |
| Cellectis S.A. | -92.63 Million USD | -81.573% |